Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Arthritis Research & Therapy 2012, 14:R216 doi:10.1186/ar4055
- Last 30 days: 83 accesses
- Last 365 days: 1250 accesses
- All time: 4711 accesses
These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information